Marthe Fourcade

Roche Holding AG said an experimental medicine helped women with a particular breast cancer mutation live longer without the disease progressing.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Argenx SE shares plunged after the Dutch biotech said preliminary results from a study suggest its only medicine failed in a trial for a rare bleeding disorder.

UK health officials have reported a person with a flu strain typically found in pigs, marking the first time this variant has been detected in a human in the country.

GSK Plc said its antibody drug Blenrep, which had its US clearance revoked last year, helped patients live longer without their blood cancer worsening in a late-stage study.

A therapy for blood disorders became the first ever gene-editing treatment to get regulatory approval for use on humans in a breakthrough for the technology, which aims to repair genetic code.

GSK Plc’s Jemperli helped extend the lives of patients with endometrial cancer in a late-stage test, suggesting the medicine could become the top seller the UK drugmaker is predicting.

GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.

Sandoz Group AG, the maker of copycat medicines that was spun off from drugmaker Novartis AG, begins life as a standalone company on Wednesday when its shares start trading on the Swiss stock exchange.

Sanofi agreed to pay Teva Pharmaceutical Industries Inc. as much as $1.5 billion to help develop and sell a medicine for inflammatory bowel disease, its second deal to gain a new experimental treatment this week.

Sanofi struck a deal to help fund and sell an experimental vaccine developed by Johnson & Johnson against an invasive form of the digestive pathogen E. coli.

Novo Nordisk A/S agreed to buy Embark Biotech, a Danish company working on appetite suppression, for up to €471 million ($512 million) as it seeks to retain its edge in the booming field of weight loss.

Specially designed spaces allow people with dementia to live freely—and could slow their decline.

Valneva SE, the French company that raced to develop a Covid shot only to find that others beat it to the punch and potential buyers were no longer interested, received another blow on Thursday: even the local regulator won’t clear its shot.

The investment firm ECP agreed to buy Biffa Plc, valuing the UK waste-management company at about £1.3 billion ($1.4 billion), its latest investment in the energy transition and sustainable businesses.

At least 17 million people in Europe experienced long Covid in the pandemic’s first two years, with many still struggling with debilitating symptoms, according to a new tally.

WHO Panel Advises Against Generic Antidepressant to Treat Covid  Bloomberg

Here’s the latest news from the pandemic.

Two years after being hospitalized with Covid-19, more than half of patients still experience symptoms like fatigue and sleep disruption, according to a study in the original epicenter of Wuhan that underscores the pandemic’s lasting burden.